November 30, 2012
Greehey Children's Cancer Research Institute
UT Health Science Center at San Antonio, 8403 Floyd Curl Drive, 78229
8:00 – 8:30 a.m.
Ian M. Thompson, MD, Director, Cancer Therapy & Research Center
8:45 – 10:45 a.m.
SESSION I: Drug Discovery Strategies
Chair: Bruce J. Nicholson, Ph.D., Co-Director of CIDD, Chair of Biochemistry
Stephen W. Fesik, PhD, Orrin H. Ingram II Chair in Cancer Research and Professor of Biochemistry, Pharmacology and Chemistry Vanderbilt University School of Medicine
Title: "Cancer Drug Discovery Using Fragment-Based Methods"
(Q&A to follow)
Stanton McHardy, PhD, Director of Medicinal Chemistry Core, UTSA
Title: "Center for innovation in Drug Discovery, Medicinal Chemistry Core at UTSA; Capabilities, Progress and Programs"
Matthew J. Hart, PhD, Assistant Professor, Research, Molecular Medicine Title:&qout;Novel soluble receptor fusions for anagonizing the tumor - and metastasis-promoting activities of TGF-beta in advanced breast and prostate cancer"
Andrew Hinck, PhD, Professor, Biochemistry, UTHSCSA
Title: "Novel Soluble receptor fusions for antagonizing the tumor-and metastasis-promoting activities of TGF-beta in advanced breast and prostate cancer"
UTHSCSA students, fellows/post-doctorates, faculty and CTRC Shared Resource leaders are eligible to present posters (only students and fellows/post-doctorates are eligible for awards)
SESSION II: Drug Development Approaches
Chair: Steve Weitman, MD, Director IDD
Donald W. Kufe, MD, Professor, Department of Medicine, Harvard Medical School; Leader, Translational Pharmacology and Early Therapeutic Trials Program, Dana-Farber/Harvard Cancer Center
Title: "MUC1 Heterodimeric Oncoprotein: Fundamental, Translational and Clinical Research"
(Q&A to follow)
Devalingam Mahalingam, MD, PhD, Assistant Professor/Clinical Hematology/Medical Oncology
Title: "Clinical Application of Oncolytic Viral Therapies"
Alexander Pertsemlidis, PhD, Associate Professor of Pediatrics, Greehey Children's Cancer Research Institute, UTHSCSA
Title: "miRNAs as potential therapeutic targets and agents"
To Register or for symposium details, visit http://www.ctrc.net/symposium<